International Journal of Tuberculosis and Lung Disease

Papers
(The H4-Index of International Journal of Tuberculosis and Lung Disease is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
TB infection in adults with diabetes mellitus in Uganda147
Clinical profile and outcomes of paediatric central nervous system tuberculomas109
TB-related deaths among adults in Guinea-Bissau82
Launch of a second wave of IJTLD Clinical Standards for Lung Health54
Ethambutol-induced optic neuropathy: should we mandate ophthalmic examination in TB treatment?47
Dr Christopher Zishiri43
Travel reimbursements, distance to health facility and preventive treatment cascade for drug-resistant TB43
Screening of refugees from Ukraine for TB: a TBnet survey42
Decentralising DOT for drug-susceptible TB from the health facilities to the community level in Togo32
Reply to ‘Estimating TB survival ‐ mind the immortal-time gap’30
CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities30
Atorvastatin to reduce bacillary load and attenuate lung damage in TB patients27
The effect of antenatal isoniazid preventive therapy on birth outcomes in Western Kenya26
Targeted therapeutic drug monitoring identifies frequent under-dosing of TB drugs24
Latent TB and depressive symptoms in household contacts of persons with active TB22
Yield of community outreach events for TB screening21
CFU counting may underestimate TB bacilli number of blood, biasing limit of detection estimates in spiking experiments19
Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease18
WHO target product profiles for TB preventive treatment18
0.076105117797852